These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 28890187)
1. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance. Mowla R; Wang Y; Ma S; Venter H Biochim Biophys Acta Biomembr; 2018 Apr; 1860(4):878-886. PubMed ID: 28890187 [TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors. Vargiu AV; Ruggerone P; Opperman TJ; Nguyen ST; Nikaido H Antimicrob Agents Chemother; 2014 Oct; 58(10):6224-34. PubMed ID: 25114133 [TBL] [Abstract][Full Text] [Related]
3. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives. Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance. Wang Y; Mowla R; Guo L; Ogunniyi AD; Rahman T; De Barros Lopes MA; Ma S; Venter H Bioorg Med Chem Lett; 2017 Feb; 27(4):733-739. PubMed ID: 28129976 [TBL] [Abstract][Full Text] [Related]
5. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump. Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV mBio; 2020 Jun; 11(3):. PubMed ID: 32487753 [TBL] [Abstract][Full Text] [Related]
6. Measuring Small Molecule Binding to Escherichia coli AcrB by Surface Plasmon Resonance. Polyak SW; Mowla R; Venter H Methods Mol Biol; 2020; 2089():119-130. PubMed ID: 31773650 [TBL] [Abstract][Full Text] [Related]
15. Perturbed structural dynamics underlie inhibition and altered efflux of the multidrug resistance pump AcrB. Reading E; Ahdash Z; Fais C; Ricci V; Wang-Kan X; Grimsey E; Stone J; Malloci G; Lau AM; Findlay H; Konijnenberg A; Booth PJ; Ruggerone P; Vargiu AV; Piddock LJV; Politis A Nat Commun; 2020 Nov; 11(1):5565. PubMed ID: 33149158 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological activity evaluation of novel 4-subtituted 2-naphthamide derivatives as AcrB inhibitors. Wang Y; Mowla R; Ji S; Guo L; De Barros Lopes MA; Jin C; Song D; Ma S; Venter H Eur J Med Chem; 2018 Jan; 143():699-709. PubMed ID: 29220791 [TBL] [Abstract][Full Text] [Related]
17. Sequential mechanism of assembly of multidrug efflux pump AcrAB-TolC. Tikhonova EB; Yamada Y; Zgurskaya HI Chem Biol; 2011 Apr; 18(4):454-63. PubMed ID: 21513882 [TBL] [Abstract][Full Text] [Related]
18. Characterization of substituted piperazines able to reverse MDR in Escherichia coli strains overexpressing resistance-nodulation-cell division (RND) efflux pumps. Casalone E; Vignolini T; Braconi L; Gardini L; Capitanio M; Pavone FS; Giovannelli L; Dei S; Teodori E J Antimicrob Chemother; 2022 Feb; 77(2):413-424. PubMed ID: 34747445 [TBL] [Abstract][Full Text] [Related]
19. [Reserpine Is the New Addition into the Repertoire of AcrB Efflux Pump Inhibitors]. Shaheen A; Afridi WA; Mahboob S; Sana M; Zeeshan N; Ismat F; Mirza O; Iqbal M; Rahman M Mol Biol (Mosk); 2019; 53(4):674-684. PubMed ID: 31397441 [TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel 4-substituted quinazoline-2-carboxamide derivatives targeting AcrB to reverse the bacterial multidrug resistance. Gu X; Pisoni LA; Wang Y; Song D; Sykes MJ; Qin Y; Semple SJ; Polyak SW; Venter H; Ma S Bioorg Chem; 2020 Dec; 105():104394. PubMed ID: 33120321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]